Phase 1 Prostate Cancer (CRPC) Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Castration-Resistant Prostate Cancer (CRPC)
Radiopharm Theranostics, Ltd61 enrolled4 locationsNCT07189871
Recruiting
Phase 1
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Metastatic Castration-resistant Prostate Cancer (CRPC)
TechnoGenesys, Inc.40 enrolled1 locationNCT06705686
Recruiting
Phase 1
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Metastatic Castrate Resistant Prostate Cancer (mCRPC)Prostate Cancer (CRPC)
ARTBIO Inc.80 enrolled3 locationsNCT07214961
Recruiting
Phase 1
Study on Human Bioequivalence of Triprerelin Acetate for Injection
Prostate Cancer (CRPC)
The Affiliated Hospital of Qingdao University120 enrolled1 locationNCT06683066